Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)

Maria Teresa Borrello, Benjamin Schinor, Katharina Bartels, Hanae Benelkebir, Sara Pereira, Wafa T. Al-Jamal, Leon Douglas, Patrick J. Duriez, Graham Packham, Günter Haufe, A. Ganesan

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)
14 Downloads (Pure)


We report a series of tranylcypromine analogues containing a fluorine in the cyclopropyl ring. A number of compounds with additional m- or p- substitution of the aryl ring were micromolar inhibitors of the LSD1 enzyme. In cellular assays, the compounds inhibited the proliferation of acute myeloid leukemia cell lines. Increased levels of the biomarkers H3K4me2 and CD86 were consistent with LSD1 target engagement.
Original languageEnglish
Pages (from-to)2099–2101
JournalBioorganic & Medicinal Chemistry Letters
Issue number10
Early online date29 Mar 2017
Publication statusPublished - 15 May 2017


  • Organofluorine compounds
  • Epigenetics
  • FAD-dependent enzymes
  • Lysine demethylase
  • Mechanism based inhibitors

Cite this